Skip to main content

Table 1 Hemodynamic and renal findings during baseline, development (DS) and intervention sepsis periods in the CG and AG groups

From: Cardiovascular effects of β-blockade in a sheep model of severe sepsis

 

Group

Baseline period

Development sepsis period (DS)

Sepsis intervention period

P value

CO

CG

3.68 (0.29)

3.68 (0.29)

4.12 (0.29)

<0.001

 

AG

3.21 (0.22)

3.21 (0.22)

5.63 (0.53)

 

HR

CG

66.0 (6.5)

66.0 (6.5)

108.8 (8.6)

<0.001

 

AG

59.7 (6.4)

59.7 (6.4)

111.6 (8.4)

 

MAP

CG

93.7 (5.1)

102.5 (3.6)

86.1 (4.1)

0.035

 

AG

96.3 (5.0)

102.5 (3.8)

81.5 (4.3)

 

RBF

CG

217.3 (14.8)

217.3 (14.8)

324.8 (19.7)

0.194

 

AG

214.7 (19.9)

214.7 (19.9)

292.3 (27.4)

 

UO

CG

31.1 (7.1)

84.1 (20.4)

22.1 (4.8)

0.097

 

AG

34.8 (7.0)

52.3 (17.4)

16.8 (11.0)

 

TPC

CG

38.2 (3.4)

38.9 (3.4)

63.9 (6.8)

0.084

 

AG

34.3 (3.1)

37.3 (3.2)

51.4 (6.8)

<0.001

SV

CG

51.4 (3.7)

39.1 (3.6)

35.5 (8.2)

0.147

 

AG

51.2 (4.6)

36.7 (3.5)

39.6 (3.6)

 

RVC

CG

2.39 (0.18)

3.26 (0.26)

3.74 (0.41)

0.55

 

AG

2.23 (0.16)

2.88 (0.26)

3.53 (0.44)

 
  1. Values are the mean (± standard error). P value: two-way repeated-measures ANOVA interaction between treatment group and time (see text for definitions).